During the past decade, ASST Lecco conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ASST Lecco" #1 sponsor was "University of Milano Bicocca" with 3 trials, followed by "European Institute of Oncology" with 2 trials sponsored, "Grupo Español de Investigación en Cáncer de Ovario" with 2 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored and "Allena Pharmaceuticals" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ASST Lecco" #1 collaborator was "Hoffmann-La Roche" with 3 trials as a collaborator, "AGO Study Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator, "MaNGO" with 2 trials as a collaborator and "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "ASST Lecco" are "Fallopian Tube Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Aortic Dissection" (1 trials), "Atrial Fibrillation" (1 trials) and "Brain Metastases From Non-small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "ASST Lecco" in a lesser frequency.

Most popular intervention types in "ASST Lecco" are "Drug" (15 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (4 trials), "Atezolizumab" (3 trials), "Carboplatin" (2 trials), "Niraparib" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "ASST Lecco" are 11 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "ASST Lecco". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ASST Lecco, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ASST Lecco, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

ASST Lecco has several departments that took part in Clinical trials: "ASST DI LECCO; Oncologia Medica" - 10 trials, "Ospedale San Leopoldo Mandic, Cardiologia - Ucc" - 4 trials